StockData
Intuitive Surgical Inc logo

Intuitive Surgical Inc (ISRG) operating KPIs

ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 17/3023% above fair value
$432.01−16.75 (-3.73%)

Close on Oct 30, 2026Market cap $152.62BP/E 49.5Yield –

Intuitive Surgical u.S. MedTech Industry Total — FDA 510(k) Premarket Clearances

U.S. FDA openFDA API (/device/510k)

QuarterlyAnnualMonthly
Latest, Q3 2026
855
Period ended Sep 30, 2026
Change on a year earlier
+7.3%
797 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
1
https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR)

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. MedTech Industry Total — FDA 510(k) Premarket ClearancesYear on yearSource
Q3 2026Sep 30, 2026855+7.3%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q2 2026Jun 30, 2026923+4.2%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q1 2026Mar 31, 2026756+2.7%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q4 2025Dec 31, 2025806-5.8%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q3 2025Sep 30, 2025797+3.9%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q2 2025Jun 30, 2025886+11.7%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q1 2025Mar 31, 2025736+3.2%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q4 2024Dec 31, 2024856-2.4%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q3 2024Sep 30, 2024767-13.1%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q2 2024Jun 30, 2024793-2.0%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q1 2024Mar 31, 2024713-8.2%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q4 2023Dec 31, 2023877+2.3%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q3 2023Sep 30, 2023883+11.3%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q2 2023Jun 30, 2023809-2.4%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q1 2023Mar 31, 2023777+6.4%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q4 2022Dec 31, 2022857+6.9%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗

Cite this data

StockData. (2026). Intuitive Surgical U.S. MedTech Industry Total — FDA 510(k) Premarket Clearances, quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Intuitive Surgical SEC filings and investor materials. https://stockdatahq.com/stocks/isrg/kpis/ext-fda-510k-us

See every metric in the Intuitive Surgical KPI table. Data updated Oct 28, 2026.